ImCare Biotech, Inc.

Biotechnology company · Doylestown, Pennsylvania, United States

ImCare Biotech, Inc. is a biotechnology company headquartered in Doylestown, Pennsylvania, United States. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $6.8 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $153,402 sold in a notice filed in 2023.

www.imcarebiotech.comProfile compiled from public records. Is this your company? Request a correction or update

ImCare Biotech at a glance

Typebiotechnology company

HeadquartersDoylestown, Pennsylvania, United States

Employees (self-reported, 2025)3

SEC CIK1806270

What does ImCare Biotech do?

US government research funding

5 SBIR/STTR small-business research awards from US health agencies, $6.8 million in total (2012 to 2025). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $153,402 sold (2023).

Frequently asked questions about ImCare Biotech

Where is ImCare Biotech headquartered?

ImCare Biotech, Inc. is headquartered in Doylestown, Pennsylvania, United States.

What does ImCare Biotech do?

ImCare Biotech, Inc. is a biotechnology company.

Similar companies

Thrombolex, Inc.Doylestown, Pennsylvania, United States
Prolifagen, Inc.Doylestown, Pennsylvania, United States
IVIEW Therapeutics IncDoylestown, Pennsylvania, United States
ImmunoGenesis, Inc.Doylestown, Pennsylvania, United States
Atrin Pharmaceuticals LLCDoylestown, Pennsylvania, United States
Fox Chase Chemical Diversity Center Inc.Doylestown, Pennsylvania, United States
Conifer Point Pharmaceuticals LLCDoylestown, Pennsylvania, United States
Chemia Biosciences, Inc.Doylestown, Pennsylvania, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-24. Data licences